OMER (STOCKS)
Omeros Corporation
$11.910000
+0.420000 (+3.66%)
Prev close: $11.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Gregory A. Demopulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $817.88M
- Employees
- 202
- P/E (TTM)
- -22.77
- P/B (TTM)
- -6.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.98 | $-0.58 | +1.5614 | +268.56% |
|
Sep 2025 (Q3)
|
$-0.47 | $-0.45 | -0.0161 | -3.55% |
|
Jun 2025 (Q2)
|
$-0.43 | $-0.49 | +0.0606 | +12.35% |
|
Mar 2025 (Q1)
|
$-0.58 | $-0.58 | -0.0020 | -0.35% |
Financial Statements
| Revenues | $0.00 |
| Costs And Expenses | $122.80M |
| Selling, General, and Administrative Expenses | $41.50M |
| Depreciation and Amortization | $1.00M |
| Research and Development | $81.30M |
| Operating Income/Loss | -$122.80M |
| Income/Loss From Continuing Operations After Tax | -$4.81M |
| Income/Loss From Continuing Operations Before Tax | -$2.80M |
| Income/Loss From Discontinued Operations Net Of Tax | $1.46M |
| Income Tax Expense/Benefit | $2.01M |
| Income Tax Expense/Benefit, Current | $2.01M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$3.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.35M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.05 |
| Diluted Earnings Per Share | -$0.05 |
| Basic Average Shares | 63,510,201 |
| Assets | $325.63M |
| Current Assets | $215.67M |
| Cash | $171.80M |
| Accounts Receivable | $10.92M |
| Other Current Assets | $32.95M |
| Noncurrent Assets | $109.97M |
| Fixed Assets | $1.77M |
| Other Non-current Assets | $108.20M |
| Liabilities | $446.86M |
| Current Liabilities | $78.06M |
| Accounts Payable | $4.76M |
| Wages | $10.35M |
| Other Current Liabilities | $62.95M |
| Noncurrent Liabilities | $368.80M |
| Long-term Debt | $87.90M |
| Other Non-current Liabilities | $280.90M |
| Equity | -$121.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$121.23M |
| Liabilities And Equity | $325.63M |
| Net Cash Flow From Operating Activities | -$116.09M |
| Net Cash Flow From Operating Activities, Continuing | -$116.09M |
| Net Cash Flow From Investing Activities | $164.52M |
| Net Cash Flow From Investing Activities, Continuing | $164.52M |
| Net Cash Flow From Financing Activities | -$42.17M |
| Net Cash Flow From Financing Activities, Continuing | -$42.17M |
| Net Cash Flow | $6.26M |
| Net Cash Flow, Continuing | $6.26M |
| Comprehensive Income/Loss | -$3.35M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.35M |
| Other Comprehensive Income/Loss | $0.00 |
| Other Comprehensive Income/Loss Attributable To Parent | $0.00 |